Skip to main content
Premium Trial:

Request an Annual Quote

RXi to Raise $7.8M in Stock, Warrant Sale

Premium

RXi Pharmaceuticals this week said it has entered into definitive agreements with undisclosed investors to sell 2,385,715 shares of its common stock at $3.50 per share and warrants to purchase up to 954,286 shares of common stock at an exercise price of $4.50 per share.

The warrants are exercisable beginning on or about Feb. 4, 2010, the company noted.

RXi said it will receive approximately $7.8 million in net proceeds from the offering, which will be used to meet working capital needs and for general corporate purposes.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.